Skip to content

aTyr Pharma ATYR Current maturities of long-term debt

Current maturities of long-term debt at other companies

L3Harris Technologies logo
L3Harris TechnologiesLHX
$10M-68.8%
T-Mobile US logo
T-Mobile USTMUS
$1.16B+1.7%
Equinix, Inc. logo
Equinix, Inc.EQIX
$173M-13.9%
Imperial Oil logo
Imperial OilIMO
$19M+5.6%
ON Semiconductor logo
ON SemiconductorON
$500K+25.0%
CoreWeave, Inc.
 logo
CoreWeave, Inc. CRWV
$23M-61.0%

Other financials

Income statement

See full
Revenue-
Operating income-$11.4M+27.5%
Net income-$10.8M+27.5%
EPS (diluted)-$0.11+35.3%

Balance sheet

See full
Cash & equivalents$10.0M-3.4%
Total debt$12.3M-9.2%
Total equity$57.9M-22.8%
Total assets$79.7M-18.1%

Cash flow

See full
Operating cash flow-$12.5M+18.8%
CapEx$138.0K
Free cash flow-$12.7M+17.9%

Valuation

See full
Market cap$54.88M-88.2%
Enterprise value$57.17M
P/S288.8×

Profitability

See full
Operating margin-40,856.3%+28,833pp
Net margin-39,009.5%+29,653pp
FCF margin-32,664.7%+4,018pp

Returns & leverage

See full
Return on equity-105.3%+50.6pp
Debt / equity0.2×0.0×
Current ratio5.8×-2.0×

Where this comes from

Reported directly by aTyr Pharma in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's current maturities of long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is aTyr Pharma's current maturities of long-term debt?
aTyr Pharma (ATYR) reported current maturities of long-term debt of $596K in Q1 2026.
How has aTyr Pharma's current maturities of long-term debt changed year-over-year?
aTyr Pharma's current maturities of long-term debt increased by 8.4% year-over-year, from $550K to $596K.